Soluble Programmed Death-Ligand 1 (sPD-L1) is Elevated in Aggressive Prostate Cancer Disease Among African Men

INTRODUCTION: Programmed death 1 (PD-1)/programmed death-ligand 1 (PD-L1)-targeted immunotherapies have become a new mode of treatment for several tumours; however, there is limited evidence on the expression and prognostic value of PD-1/PD-L1 in prostate cancer, especially in African men. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Katongole, Paul, Sande, Obondo J., Reynolds, Steven J., Joloba, Moses, Kajumbula, Henry, Kalungi, Samuel, Ssebambulidde, Kenneth, Nakimuli, Cynthia, Atuheirwe, Maxine, Orem, Jackson, Niyonzima, Nixon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9098749/
https://www.ncbi.nlm.nih.gov/pubmed/35128628
http://dx.doi.org/10.1007/s40487-022-00184-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9098749/
https://www.ncbi.nlm.nih.gov/pubmed/35128628
http://dx.doi.org/10.1007/s40487-022-00184-6

Ejemplares similares